In vitro and in vivo antitumor effect of 2-methoxyestradiol on human melanoma

International Journal of Cancer

Volumn 112, Issue 5, 2004, Pages 771-776

  Dobos, Judit ^a   Tímár, József ^a   Bocsi, József ^b   Burián, Zsuzsanna ^a   Nagy, Katalin ^b   Barna, Gábor ^b   Peták, István ^b   Ladányi, Andrea ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

2 methoxyestradiol; Apoptosis; Melanoma; Metastasis

Indexed keywords

2 METHOXYESTRADIOL; CASPASE; ESTRADIOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G2 PHASE; CELL DAMAGE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; EMBRYO; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER METASTASIS; MALE; MELANOMA; MELANOMA CELL; MICROTUBULE; MITOCHONDRION; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; TUMOR VOLUME;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; ESTRADIOL; HUMANS; MALE; MELANOMA; MICE; MICE, SCID; NEOPLASMS, EXPERIMENTAL; SKIN NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 7244245430     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20473     Document Type: Article

References (43)

1. Miller JG, Mac Neil S. Gender and cutaneous melanoma. Br J Dermatol 1997;136:657-65.
2. Kemeny MM, Busch E, Stewart AK, Menck HR. Superior survival of young women with malignant melanoma. Am J Surg 1998;175:437-45.
3. Proctor JW, Auclair BG, Stokowski L. Endocrine factors and the growth and spread of B16 melanoma. J Natl Cancer Inst 1976;57: 1197-8.
4. Walker MJ, Chaudhuri PK, Das Gupta TK, Beattie CW. Influence of host sex on the growth of human melanoma. Proc Soc Exp Biol Med 1980;165:96-9.
5. Ladányi A, Tímár J, Bocsi J, Tóvári J, Lapis K. Sex-dependent liver metastasis of human melanoma lines in SCID mice. Melanoma Res 1995;5:83-6.
6. Cohen C, DeRose PB, Campbell WG, Schlosnagle DC, Sgoutas D. Estrogen receptor status in malignant melanoma. Am J Dermatopathol. 1990;12:562-4.
7. Feucht KA, Walker MJ, Das Gupta TK, Beattie CW. Effect of 17β-estradiol on the growth of estrogen receptor-positive human melanoma in vitro and in athymic mice. Cancer Res 1988;48:7093-101.
8. Richardson B, Price A, Wagner M, Williams V, Lorigan P, Browne S, Miller JG, Mac Neil S. Investigation of female survival benefit in metastatic melanoma. Br J Cancer 1999;80:2025-33.
9. Neifeld JP, Lippman ME. Steroid hormone receptors and melanoma. J Invest Dermatol 1980;74:379-81.
10. Pribluda VS, Gubish ER, LaVallee TM, Treston A, Swartz GM, Green SJ. 2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate. Cancer Metastasis Rev 2000;19: 173-9.
11. Schumacher G, Neuhaus P. The physiological estrogen metabolite 2-methoxyestradiol reduces tumor growth and induces apoptosis in human solid tumors. J Cancer Res Clin Oncol 2001;127:405-10.
12. Zhu BT, Conney AH. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 1998;19:1-27.
13. LaVallee TM, Zhan XH, Herbstritt CJ, Kough EC, Green SJ. Pribluda VS. 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors α and β. Cancer Res 2002;62: 3691-7.
14. Fotsis T, Zhang Y, Pepper MS, Adlercreutz H, Montesano R, Nawroth PP, Schweigerer L. The endogenous oestrogen metabolite 2-methoxyestradiol inhibits angiogenesis and suppresses tumor growth. Nature 1994;368:237-9.
15. Klauber N, Parangi S, Flynn E, Hamel E, D'Amato RJ. Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res 1997;57:81-6.
16. Yue T-L, Wang X, Louden CS, Gupta S, Pillarisetti K, Gu J-L, Hart TK, Lysko PG, Feuerstein GZ. 2-Methoxyestradiol, an endogenous estrogen metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: possible role for stress-activated protein kinase signaling pathway and Fas expression. Mol Pharmacol 1997;51:951-62.
17. Schumacher G, Kataoka M, Roth JA, Mukhopadhyay T. Potent antitumor activity of 2-methoxyestradiol in human pancreatic cancer cell lines. Clin Cancer Res 1999;5:493-9.
18. 2/M arrest and apoptosis in prostate cancer. Biochem Biophys Res Commun 2001; 285:1259-66.
19. Qanungo S, Basu A, Das M, Haldar S. 2-Methoxyestradiol induces mitochondria dependent apoptotic signaling in pancreatic cancer cells. Oncogene 2002;21:4149-57.
20. Dingli D, Timm M, Russell SJ, Witzig TE, Rajkumar SV. Promising preclinical activity of 2-methoxyestradiol in multiple myeloma. Clin Cancer Res 2002;8:3948-54.
21. Kataoka M, Schumacher G, Cristiano RJ, Atkinson EN, Roth JA, Mukhopadhyay T. An agent that increases tumor suppressor transgene product coupled with systemic transgene delivery inhibits growth of metastatic lung cancer in vivo. Cancer Res 1998;58:4761-5.
22. D'Amato R, Lin CM, Flynn E, Folkman J, Hamel E. 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polimerization by interacting at the colchicine site. Proc Natl Acad Sci USA 1994;91:3964-8.
23. Attalla H, Mäkelä TP, Adlercreutz H, Andersson LC. 2-Methoxyestradiol arrests cells in mitosis without depolymerizing tubulin. Biochem Biophys Res Commun 1996;228:467-73.
24. Attalla H, Westberg JA, Andersson LC, Adlercreutz H, Mäkelä TP. 2-Methoxyestradiol-induced phosphorylation of Bcl-2: uncoupling from JNK/SAPK activation. Biochem Biophys Res Commun 1998; 247:616-9.
25. 2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 2003;3:363-75
26. Mukhopadhyay T, Roth JA. Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methoxyestradiol. Oncogene 1997;14:379-84.
27. Huang P, Feng L, Oldham EA, Keating MJ, Plunkett W. Superoxide dismutase as a target for the selective killing of cancer cells. Nature 2000;407:390-5.
28. LaVallee TM, Zhan XH, Johnson MS, Herbstritt CJ, Swartz G, Williams MS, Hembrough WA, Green SJ, Pribluda VS. 2-Methoxyestradiol up-regulates death receptor 5 and induces apoptosis through activation of the extrinsic pathway. Cancer Res 2003;63:468-75.
29. Ghosh R, Ott AM, Seetharam D, Slaga TJ, Kumar AP. Cell cycle block and apoptosis induction in a human melanoma cell line following treatment with 2-methoxyestradiol: therapeutic implications? Melanoma Res 2003;13:119-27.
30. Ladányi A, Tímár J, Paku S, Molnár G, Lapis K. Selection and characterization of human melanoma lines with different liver-colonizing capacity. Int J Cancer 1990;46:456-61.
31. Martin A, Clynes M. Comparison of 5 microplate colorimetric assays for in vitro cytotoxicity testing and cell proliferation assays. Cytotechnology 1993;11:49-58.
32. Gong J, Traganos F, Darzynkiewicz Z. A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal Biochem 1994;218:314-9.
33. Mihalik R, Uher F, Pocsik EE, Berczi L, Benczur M, Kopper L. Detection of drug-induced apoptosis by flow cytometry after alkaline extraction of ethanol fixed cells. Pathol Oncol Res 1996;2:78-83.
34. Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssiere JL, Petit PX, Kroemer G. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med 1995;181:1661-72.
35. Kopper L, Hahn TV, Lapis K. Experimental model for liver metastasis formation using Lewis lung tumor. J Cancer Res Clin Oncol 1982; 103:31-8.
36. Bu S, Blaukat A, Fu X, Heldin N-E, Landström M. Mechanisms for 2-methoxyestradiol-induced apoptosis of prostate cancer cells. FEBS Lett 2002;531:141-51.
37. Chauhan D, Catley L, Hideshima T, Li G, Leblanc R, Gupta D, Sattler M, Richardson P, Schlossman RL, Podar K, Weller E, Munshi N, Anderson KC. 2-Methoxyestradiol overcomes drug resistance in multiple myeloma cells. Blood 2002;100:2187-94.
38. Soengas MS, Lowe SW. Apoptosis and melanoma chemoresistance. Oncogene 2003;22:3138-51.
39. Helmbach H, Sinha P, Schadendorf D. Human melanoma: drug resistance. Recent Results Cancer Res 2003;161:93-110.
40. Shimada K, Nakamura M, Ishida E, Kishi M, Konishi N. Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis. Carcinogenesis 2003;24:1067-75.
41. Djavaheri-Mergny M, Wietzerbin J, Besançon F. 2-Methoxyestradiol induces apoptosis in Ewing sarcoma cells through mitochondrial hydrogen peroxide production. Oncogene 2003;22:2558-67.
42. Li X-F, Kinuya S, Yokoyama K, Koshida K, Mori H, Shiba K, Watanabe N, Shuke N, Michigishi T, Tonami N. Benefits of combined radioimmunotherapy and anti-angiogenic therapy in a liver metastasis model of human colon cancer cells. Eur J Nucl Med 2002;29:1669-74.
43. Lakhani NJ, Sarkar MA, Venitz J, Figg WD. 2-Methoxyestradiol, a promising anticancer agent. Pharmacotherapy 2003;23:165-72.